Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-017318
Filing Date
2024-05-01
Accepted
2024-04-30 20:43:12
Documents
17

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 2372345
2 ex1-1.htm EX-1.1 352270
3 ex4-1.htm EX-4.1 99361
4 ex5-1.htm EX-5.1 11662
5 ex10-30.htm EX-10.30 48156
6 ex10-31.htm EX-10.31 24351
7 ex10-32.htm EX-10.32 28845
8 ex10-33.htm EX-10.33 23255
9 ex10-34.htm EX-10.34 27569
10 ex10-35.htm EX-10.35 23575
11 ex10-36.htm EX-10.36 18444
12 ex23-1.htm EX-23.1 4486
13 logo_003.jpg GRAPHIC 4863
14 chart_002.jpg GRAPHIC 220685
15 chart_022.jpg GRAPHIC 273662
16 logo_001.jpg GRAPHIC 3581
17 ex5-1_001.jpg GRAPHIC 3320
  Complete submission text file 0001493152-24-017318.txt   3732941
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-274805 | Film No.: 24899577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)